CN216855017U

CN216855017U - Slow-release chlorine dioxide adhesive bandage

Info

Publication number: CN216855017U
Application number: CN202122122599.4U
Authority: CN
Inventors: 胡毛头
Original assignee: Shanghai Tushuang Enterprise Management Service Center LP
Current assignee: Shanghai Tushuang Enterprise Management Service Center LP
Priority date: 2021-09-03
Filing date: 2021-09-03
Publication date: 2022-07-01
Anticipated expiration: 2031-09-03

Abstract

The utility model designs a sustained-release chlorine dioxide bandage which comprises an adhesive plaster and a non-toxic film protective layer, and is characterized in that two non-toxic film protective layers are respectively stuck at two ends of the adhesive plaster, and an interlayer consisting of a macromolecular breathable film is arranged on the adhesive plaster. The utility model has the advantages that the utility model can be conveniently stuck on wounds, has the effects of three-dimensional disinfection and protection for a long time, has more obvious disinfection effect, can effectively control the inflammation of the wounds, has longer effective action time for single use, and improves the safety and effectiveness of use. When in use, the pure gaseous chlorine dioxide active substance is released in an effective range in a quantitative and slow-release manner, the release dosage is extremely low, and the pollution to the environment is avoided.

Description

Slow-release chlorine dioxide adhesive bandage

Technical Field

The utility model mainly relates to the technical field of living and medical disinfection articles, in particular to a slow-release chlorine dioxide disinfection bandage.

Background

The disinfectant used in the utility model is chlorine dioxide gas, and the chlorine dioxide disinfectant is an internationally recognized high-efficiency disinfectant, can kill all microorganisms including bacterial propagules, bacterial spores, fungi, mycobacteria, viruses and the like, and the bacteria can not generate drug resistance. Chlorine dioxide has strong adsorption and penetration capacity on microbial cell walls, can effectively oxidize enzymes containing sulfydryl in cells, and can quickly inhibit the synthesis of microbial proteins to destroy microbes.

ClO2 is a broad-spectrum disinfectant, and has good effect of killing all pathogenic microorganisms spread through water. Chlorine dioxide has good killing effect on spores, viruses, heterotrophic bacteria, iron bacteria, sulfate reduction, fungi and the like besides the killing effect on common bacteria, is not easy to generate drug resistance, and especially has good killing and inhibiting effects on typhoid fever, hepatitis A, hepatitis B, poliomyelitis, AIDS viruses and the like. ClO2 was more effective at inactivating viruses than ozone (O3) and Cl 2. Low doses of chlorine dioxide also have a strong vermicidal effect. Acute oral toxicity tests show that the chlorine dioxide disinfectant is a practical non-toxic product, and the conclusion of the accumulative tests is that the chlorine dioxide disinfectant is a weak accumulative substance. The water body disinfected by the disinfectant does not damage oral mucosa, involucra and scalp, and the disinfectant is absolutely safe in acute toxicity and genetic toxicology. Chlorine dioxide does not react with organic matters in water to generate carcinogenic substances such as trihalomethane and the like, and has no carcinogenic, teratogenic and mutagenic effects on higher animal cells, sperms and chromosomes. The oxidative degradation of organic substances is mainly carried out by oxygen-containing group small molecular compounds, the products are proved to be non-toxic until the present research, and ClO2 is used at an extremely low dosage of about 0.1PPM, so that the products are safe to disinfect by ClO2 and have no residual toxicity. Its safety is rated AI by the World Health Organization (WHO). Currently, the band-aid on the whole international market has 3 types of Funicillin band-aid (characteristics: short-time disinfection and antisepsis effect on wounds and no obvious effect on suppuration) of Yunnan white drug powder band-aid (characteristics: hemostasis and anti-inflammation effects, unobvious wound disinfection effect and small-area wound application), namely a common Bundy band-aid (characteristics: ineffective effect on pseudomonas aeruginosa, acid-fast bacillus and bacterial spores, and obviously reduced disinfection effect when meeting blood, cellulose and organic matters), the above 3 types of band-aid are all characterized by incomplete disinfection, short effective disinfection effect time (about 30 minutes effective action time), and extremely limited disinfection effect. The utility model 4 th adhesive bandage is slow-release chlorine dioxide adhesive bandage, (which is characterized by broad-spectrum sterilization, long-lasting sterilization for more than 8 hours, sterilization effect on the inside and outside of a wound, large effective sterilization range, good safety and no side effect), and the use is also convenient, and the production process is the same as the traditional method, a special nano ultrathin waterproof slow-release soft breathable film is adopted, a stable chlorine dioxide intermediate coating in the breathable film is activated, chlorine dioxide gas is released through the breathable film, the wound part is comprehensively and stereoscopically sterilized, and the wound is not directly contacted with the disinfectant, so that the wound is not painful when in use, is more comfortable and safe to use, and is also suitable for bandaging the wound with a large area), the production cost of the product is not higher than that of other 3 types, so the slow-release chlorine dioxide adhesive bandage of the patent can gradually replace the traditional adhesive bandage of the prior art, is a good product of updating generation and has huge global market demand. Experiments on part of samples and detection data of a professional third party show that the disinfection effect of the slow-release chlorine dioxide adhesive bandage is 5 times that of the first 3 types, and the effective action time of the slow-release chlorine dioxide adhesive bandage is 20 times that of the first 3 types. The product shelf life was equivalent to the first 3. And the product safety is higher than that of the first 3. The product can be applied to national second class medical instruments and disinfection letters. And can apply for international required FDA \ EPA, etc.

Disclosure of Invention

The object of the present invention is to overcome the above-mentioned problems of the prior art. Provides a slow-release chlorine dioxide adhesive bandage. The utility model designs a sustained-release chlorine dioxide wound plaster, which comprises an adhesive plaster (1) and a non-toxic film protective layer (4), and is characterized in that two non-toxic film protective layers (4) are respectively stuck at two ends of the adhesive plaster (1), and an interlayer (3) consisting of a high-molecular breathable film is arranged on the adhesive plaster (1). The interlayer (3) composed of the high polymer breathable films is an interlayer with an opening at one side and is sealed by a hot pressing or ultrasonic process at three edge sealing edges, and the interlayer (3) composed of the high polymer breathable films is fixed at the middle position of the adhesive tape (1) by a bonding agent (5). One inner layer surface of the interlayer composed of the high molecular breathable films is coated with a stable chlorine dioxide coating (6), the other inner layer surface is coated with an acid activator coating (2), a PET film (7) is arranged between the stable chlorine dioxide coating (6) and the acid activator coating (2), and the PET isolation film is exposed out of an opening on one side of the interlayer composed of the high molecular breathable films. The length of the PET isolation film exposed at the opening of one side of the interlayer consisting of the high-molecular breathable films is 0.8-1.5 CM.

The utility model has the advantages that the wound dressing can be conveniently pasted on a wound, has the three-dimensional disinfection and protection effects for a longer time, has more obvious disinfection effect, can effectively control the inflammation of the wound, has longer effective action time for single use, and improves the safety and effectiveness of use.

When the utility model is used, only the pure gaseous chlorine dioxide active substance is released in an effective range in a quantitative and sustained manner, the release dosage is extremely low, the environment is not polluted, the disinfection efficiency is high, and no side effect is caused. And the used effective substance is a safe green disinfectant approved by WHO, passes through the American FDA and EPA certification, and is the innovation and development of the disinfection technology.

Drawings

FIG. 1 is a schematic diagram of a structure of the present invention.

The labels in the figure are as follows:

(1) the coating comprises an adhesive tape with adhesive on one side, (2) an acid activator coating, (3) a high-molecular breathable film interlayer, (4) a non-toxic film protective layer, (5) adhesive colloid, (6) a stable chlorine dioxide coating, and (7) a PET isolation layer.

Detailed Description

The following detailed description of the embodiments of the present invention will be given in conjunction with the accompanying drawings to make it clear to those skilled in the art how to practice the present invention. While the utility model has been described in connection with preferred embodiments thereof, these embodiments are merely illustrative, and not restrictive, of the scope of the utility model.

A slow-release chlorine dioxide wound plaster comprises an adhesive plaster (1) and a non-toxic film protective layer (4), and is characterized in that two non-toxic film protective layers (4) are respectively adhered to two ends of the adhesive plaster (1), and an interlayer (3) consisting of a high-molecular breathable film is arranged on the adhesive plaster (1). The interlayer (3) composed of the high molecular breathable films is a three-edge sealed by a hot pressing or ultrasonic process, one edge of the interlayer is provided with an opening, and the interlayer (3) composed of the high molecular breathable films is fixed at the middle position of the adhesive tape (1) by a bonding agent (5). One inner layer surface of the interlayer composed of the high molecular breathable films is coated with a stable chlorine dioxide coating (6), the other inner layer surface is coated with an acid activator coating (2), a PET film (7) is arranged between the stable chlorine dioxide coating (6) and the acid activator coating (2), and the PET isolation film is exposed out of an opening on one side of the interlayer composed of the high molecular breathable films. The length of the PET isolation film exposed out of the opening at one side of the interlayer consisting of the high-molecular breathable films is 0.8-1.5 CM.

As shown in the figure, the macromolecular membrane sustained-release chlorine dioxide adhesive bandage comprises a binding adhesive tape (1) of a main body, two nontoxic membrane protective layers (4) are respectively arranged at two ends of the binding adhesive tape, substances (6) and (2) of an interlayer are implemented by adopting a spraying process, the interlayer seal is sealed by adopting a hot pressing or ultrasonic process to seal three sides, and a middle PET isolation layer is arranged in the middle of the interlayer after adopting a die cutting mode. And fixed in the intermediate position by means of an adhesive (5).

The interlayer (3) is a breathable high-molecular flexible non-woven fabric.

The interlayer (3) is a coating of stable chlorine dioxide and an acidic activator.

The installation process is as follows:

(1) spraying stable chlorine dioxide colloid on one side of the non-woven fabric.

(2) Spraying the acid activator colloid on one side of the non-woven fabric.

(3) Sealing the upper non-woven fabric, the middle PET and the lower non-woven fabric into a three-side sealed open pocket by hot pressing or ultrasonic waves, and exposing the middle layer to 1 CM.

(4) The interlayer is adhered to the middle part of the adhesive bandage.

(5) And sticking non-toxic protective films to the two ends.

When in use, the PET isolating membrane (7) is firstly drawn out to ensure that the coating substances (6) and (2) are fully contacted, so that the stable chlorine dioxide coating (6) in the interlayer is activated and generates trace chlorine dioxide gas rapidly, and then the chlorine dioxide gas is slowly released and permeated through the high molecular breathable membrane (3) to carry out three-dimensional disinfection and protection on the wound using position and the surrounding small area. The disinfection mode is a three-dimensional disinfection of a gaseous state continuous slow release mode, and the disinfection substance has certain permeability. The released chlorine dioxide gas is very low concentration, about 1 PPM.

It should be noted that many variations and modifications of the embodiments of the present invention fully described are possible and are not to be considered as limited to the specific examples of the above embodiments. The above examples are given by way of illustration of the utility model and are not intended to limit the utility model. In conclusion, the scope of the present invention shall include those alterations or substitutions and modifications which are obvious to those of ordinary skill in the art, and shall be subject to the appended claims.

Claims

1. A slow-release chlorine dioxide wound plaster comprises an adhesive plaster (1) and a non-toxic film protective layer (4), and is characterized in that two non-toxic film protective layers (4) are respectively adhered to two ends of the adhesive plaster (1), and an interlayer (3) consisting of a high-molecular breathable film is arranged on the adhesive plaster (1).

2. The sustained-release chlorine dioxide wound plaster according to claim 1, characterized in that the interlayer (3) composed of the polymeric breathable film is a three-edge-sealed interlayer sealed by a hot-pressing or ultrasonic process, one edge of the interlayer is open, and the interlayer (3) composed of the polymeric breathable film is fixed at the middle position of the adhesive plaster (1) by an adhesive (5).

3. The wound covering with slow-release chlorine dioxide according to claim 1, characterized in that one inner layer of the interlayer composed of the polymeric breathable films is coated with a stable chlorine dioxide coating (6), the other inner layer is coated with an acid activator coating (2), a layer of PET film (7) is arranged between the stable chlorine dioxide coating (6) and the acid activator coating (2), and the PET film is exposed at one opening of the interlayer composed of the polymeric breathable films.

4. The wound covering with slow-release chlorine dioxide according to claim 3, characterized in that the length of the PET barrier film exposed at the opening at one side of the interlayer composed of the high-molecular breathable films is 0.8-1.5 CM.